Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
18.17 (1y: +10%)
Market Cap 244.67 M P/E(ttm) 18.20
Enterprise Value 281.12 M P/B 1.40
EXAC- NAS (USA)
Exactech, Inc.
  • Currently 5/5
Business Predictability Rank: 5-Star
Back Testing Results:
Average gain of all 5-Star stocks: 12.1% per year.
% of Stocks that are in still loss if held for 10yrs: 3%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$18.17
Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry		 vs
history
Cash to Debt 0.142
EXAC's Cash to Debt is ranked lower than
85% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3750.67 vs. EXAC: 0.142 )
EXAC' s 10-Year Cash to Debt Range
Min: 0.03   Max: 0.78
Current: 0.14
0.03
0.78
Equity to Asset 0.586
EXAC's Equity to Asset is ranked higher than
53% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 0.53 vs. EXAC: 0.586 )
EXAC' s 10-Year Equity to Asset Range
Min: 0.53   Max: 0.77
Current: 0.59
0.53
0.77
Interest Coverage 14.8
EXAC's Interest Coverage is ranked lower than
56% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 420.30 vs. EXAC: 14.8 )
EXAC' s 10-Year Interest Coverage Range
Min: 7   Max: 69
Current: 14.8
7
69
F-Score: 7
Z-Score: 4.21
M-Score: -2.94
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry		 vs
history
Operating margin (%) 9.50
EXAC's Operating margin (%) is ranked higher than
65% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 5.80 vs. EXAC: 9.50 )
EXAC' s 10-Year Operating margin (%) Range
Min: 6.7   Max: 20.5
Current: 9.5
6.7
20.5
Net-margin (%) 5.7
EXAC's Net-margin (%) is ranked higher than
63% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.25 vs. EXAC: 5.7 )
EXAC' s 10-Year Net-margin (%) Range
Min: 4.3   Max: 10
Current: 5.7
4.3
10
ROE (%) 7.5
EXAC's ROE (%) is ranked higher than
59% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 4.80 vs. EXAC: 7.5 )
EXAC' s 10-Year ROE (%) Range
Min: 5.7   Max: 13.2
Current: 7.5
5.7
13.2
ROA (%) 5.2
EXAC's ROA (%) is ranked higher than
64% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.40 vs. EXAC: 5.2 )
EXAC' s 10-Year ROA (%) Range
Min: 3.8   Max: 9.4
Current: 5.2
3.8
9.4
ROC (Joel Greenblatt) (%) 12.10
EXAC's ROC (Joel Greenblatt) (%) is ranked higher than
53% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 14.00 vs. EXAC: 12.10 )
EXAC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 8.4   Max: 22.5
Current: 12.1
8.4
22.5
Revenue Growth (%) 5.2
EXAC's Revenue Growth (%) is ranked higher than
79% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. EXAC: 5.2 )
EXAC' s 10-Year Revenue Growth (%) Range
Min: 5.2   Max: 14.2
Current: 5.2
5.2
14.2
EBITDA Growth (%) 10.4
EXAC's EBITDA Growth (%) is ranked higher than
80% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: -1.10 vs. EXAC: 10.4 )
EXAC' s 10-Year EBITDA Growth (%) Range
Min: 1.6   Max: 15.1
Current: 10.4
1.6
15.1
EPS Growth (%) 10.2
EXAC's EPS Growth (%) is ranked higher than
73% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 2.10 vs. EXAC: 10.2 )
EXAC' s 10-Year EPS Growth (%) Range
Min: -6.3   Max: 18.5
Current: 10.2
-6.3
18.5
» EXAC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

EXAC Guru Trades in Q2 2012

Chuck Royce 1,292,259 sh (+2.59%)
Mario Gabelli 582,915 sh (+1.46%)
» More
Q3 2012

EXAC Guru Trades in Q3 2012

Chuck Royce 1,309,259 sh (+1.32%)
Mario Gabelli 588,015 sh (+0.87%)
» More
Q4 2012

EXAC Guru Trades in Q4 2012

Jim Simons 16,800 sh (New)
Mario Gabelli 593,535 sh (+0.94%)
Chuck Royce 1,177,259 sh (-10.08%)
» More
Q1 2013

EXAC Guru Trades in Q1 2013

Mario Gabelli 642,008 sh (+8.17%)
Jim Simons 17,200 sh (+2.38%)
Chuck Royce 1,017,431 sh (-13.58%)
» More
» Details

Insider Trades

Latest Guru Trades with EXAC

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mario Gabelli 2011-03-31 Reduce -38.57%0.04%$16.25 - $19.17 $ 18.171%576415
Premium More recent guru trades are included for Premium Members only!!

Ratios

vs
industry		 vs
history
P/E(ttm) 18.20
EXAC's P/E(ttm) is ranked higher than
69% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 24.10 vs. EXAC: 18.20 )
EXAC' s 10-Year P/E(ttm) Range
Min: 13.63   Max: 38.52
Current: 18.2
13.63
38.52
P/B 1.40
EXAC's P/B is ranked higher than
67% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.99 vs. EXAC: 1.40 )
EXAC' s 10-Year P/B Range
Min: 1.12   Max: 4.94
Current: 1.4
1.12
4.94
P/S 1.08
EXAC's P/S is ranked higher than
67% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. EXAC: 1.08 )
EXAC' s 10-Year P/S Range
Min: 0.85   Max: 3.54
Current: 1.08
0.85
3.54
PFCF 34.50
EXAC's PFCF is ranked lower than
68% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 18.60 vs. EXAC: 34.50 )
EXAC' s 10-Year PFCF Range
Min: 15.45   Max: 200.56
Current: 34.5
15.45
200.56
EV-to-EBIT 12.5
EXAC's EV-to-EBIT is ranked higher than
71% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 16.25 vs. EXAC: 12.5 )
EXAC' s 10-Year EV-to-EBIT Range
Min: 8.4   Max: 25.6
Current: 12.5
8.4
25.6
PEG 2.3
EXAC's PEG is ranked lower than
72% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.23 vs. EXAC: 2.3 )
EXAC' s 10-Year PEG Range
Min: 1.23   Max: 4.48
Current: 2.3
1.23
4.48
Shiller P/E 21.3
EXAC's Shiller P/E is ranked higher than
87% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 23.60 vs. EXAC: 21.3 )
EXAC' s 10-Year Shiller P/E Range
Min: 15.71   Max: 53.41
Current: 21.3
15.71
53.41

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 3.6
EXAC's Price/Net Current Asset Value is ranked higher than
53% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 8.90 vs. EXAC: 3.6 )
EXAC' s 10-Year Price/Net Current Asset Value Range
Min: 3.4   Max: 8.3
Current: 3.6
3.4
8.3
Price/Tangible Book 1.7
EXAC's Price/Tangible Book is ranked higher than
50% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.80 vs. EXAC: 1.7 )
EXAC' s 10-Year Price/Tangible Book Range
Min: 1.6   Max: 3.9
Current: 1.7
1.6
3.9
Price/DCF (Projected) 2.2
EXAC's Price/DCF (Projected) is ranked higher than
95% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.25 vs. EXAC: 2.2 )
EXAC' s 10-Year Price/DCF (Projected) Range
Min: 2   Max: 6.9
Current: 2.2
2
6.9
Price/Median PS Value 0.6
EXAC's Price/Median PS Value is ranked higher than
63% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 0.80 vs. EXAC: 0.6 )
EXAC' s 10-Year Price/Median PS Value Range
Min: 0.6   Max: 1.6
Current: 0.6
0.6
1.6
Price/Peter Lynch Fair Value 2.7
EXAC's Price/Peter Lynch Fair Value is ranked higher than
96% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 2.10 vs. EXAC: 2.7 )
EXAC' s 10-Year Price/Peter Lynch Fair Value Range
Min: 1.7   Max: 4.3
Current: 2.7
1.7
4.3
Price/Graham Number 1.2
EXAC's Price/Graham Number is ranked higher than
70% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.80 vs. EXAC: 1.2 )
EXAC' s 10-Year Price/Graham Number Range
Min: 1.1   Max: 2.2
Current: 1.2
1.1
2.2
Earnings Yield (Greenblatt) 8.00
EXAC's Earnings Yield (Greenblatt) is ranked higher than
81% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 5.95 vs. EXAC: 8.00 )
EXAC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.9   Max: 11.9
Current: 8
3.9
11.9
Forward Rate of Return (Yacktman) 5.76
EXAC's Forward Rate of Return (Yacktman) is ranked higher than
82% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.03 vs. EXAC: 5.76 )
EXAC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 4.2   Max: 17.8
Current: 5.76
4.2
17.8

Business Description

Exactech, Inc. was incorporated in Florida. The Company develops, manufactures, markets, distributes and sells orthopaedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians in the United States and internationally. It manufactures some components of its knee, extremity, and hip joint replacement systems at its facility in Gainesville, Florida, utilizing modern, highly automated computer aided manufacturing equipment. The company's cellular based manufacturing processes, which are organized in groups, or cells, are dedicated to specific product lines to minimize change-over and increase efficiency, and are designed to help it reduce the company's production cycle times while permitting flexibility to adjust quickly to changes in demand. To supplement its manufacturing of components, the company has formed strategic alliances with suppliers and business partners to externally manufacture some components. Additionally, it acquires and distributes other products and services through exclusive agreements, such as its agreement with Tecres (r) S.p.A, and non-exclusive agreements, such as with RTI Biologics, Inc. or RTI and Biomatlante SARL. In marketing its products, the company uses a combination of traditional targeted media marketing together with its main marketing focus, direct customer contact and service to orthopaedic surgeons. Products include: Knee Implants, Hip Implants, Biologics and Spine, Extremities.The Company markets its orthopaedic implant products in the United States through a network of independent sales agencies and direct sales representatives. Its competitors in the orthopaedic device market are DePuy, Inc., a division of Johnson and Johnson, Zimmer, Inc., a subsidiary of Zimmer Holdings, Inc., Stryker Howmedica Osteonics, a subsidiary of Stryker Corp., Smith and Nephew plc, and Biomet Orthopaedics, a subsidiary of Biomet, Inc. Healthcare is heavily regulated by the federal government and by state and local governments.
Company Website
SEC Reports
Industry: Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ
» More Articles for EXAC

Headlines

Articles On GuruFocus.com
Exactech Inc. Reports Operating Results (10-K) Mar 16 2011 
Exactech Inc. Reports Operating Results (10-Q) Nov 09 2010 
Chuck Royce’s Top Predictable Companies: MEDNAX, Techne Corp., ITT Educational Services, Exactech May 17 2010 
Exactech Inc. Reports Operating Results (10-Q) May 05 2010 
Exactech Inc. (EXAC) CFO and Treasurer Joel C Phillips sells 2,497 Shares May 04 2010 
Exactech Inc. (EXAC) CEO and Chairman, 10% Owner R William Petty sells 20,000 Shares Dec 11 2009 
Exactech Inc. Reports Operating Results (10-Q) Nov 05 2009 
Exactech Inc. Reports Operating Results (10-Q) Aug 06 2009 
Exactech Inc. Reports Operating Results (10-Q) May 08 2009 

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial